Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

An interdisciplinary team of researchers led by Indiana University bioengineer Feng Guo has developed a tool that could lead to improved cancer immunotherapy. The prototype platform facilitates automated drug screening and real-time, 3D imaging and analysis of interactions between immune cells and cancer cells. The team’s findings were recently published in Proceedings of the National Academy of Sciences.